Autosomal dominant PKD Treatment

Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome [1].
Mutations of either PKD1 or PKD2 cause autosomal dominant polycystic kidney disease, a syndrome characterized by extensive formation of renal cysts and progressive renal failure [2].

Autosomal dominant PKD Treatment ("ADPKD", "autosomal dominant PKD" or "Adult-onset PKD") is an inherited systemic disorder that predominantly affects the kidneys, but may affect other organs including the liver, pancreas, brain, and arterial blood vessels. Approximately 50% of people with this disease will develop end stage kidney disease and require dialysis or kidney transplantation. Progression to end stage kidney disease usually happens in the 4th to 6th decades of life.[1] Autosomal dominant polycystic kidney disease occurs

PKD Treatment is a progressive, genetic disorder of the kidneys. It occurs in humans and other organisms.PKD Treatment is characterised by the presence of multiple cysts (polycystic) in both kidneys. The disease can also damage the liver, pancreas and rarely the heart and brain. The two major forms of polycystic kidney disease are distinguished by their patterns of inheritance.

With the advent of medical technology, we knew that my other uncle was also afflicted with PKD, and when he was sufficiently ill to require dialysis, he was on the kidney transplant waiting list. When the time came that a kidney was available, they required that a transplant patient be otherwise healthy, and an X-Ray showed a spot on one of his lungs, which ultimately resulted in the loss of the opportunity for that kidney transplant.

http://www.sjzkidneyhospital.com/tags.php?/PKD+Treatment/